- Home
- WDAY vs BSX Comparison
WDAY vs BSX Comparison
Compare WDAY & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDAY
- BSX
- Stock Information
- Founded
- WDAY 2005
- BSX 1979
- Country
- WDAY United States
- BSX United States
- Employees
- WDAY N/A
- BSX N/A
- Industry
- WDAY EDP Services
- BSX Medical/Dental Instruments
- Sector
- WDAY Technology
- BSX Health Care
- Exchange
- WDAY Nasdaq
- BSX Nasdaq
- Market Cap
- WDAY N/A
- BSX 138.5B
- IPO Year
- WDAY 2012
- BSX 1992
- Fundamental
- Price
- WDAY $239.53
- BSX $101.91
- Analyst Decision
- WDAY Buy
- BSX Strong Buy
- Analyst Count
- WDAY 29
- BSX 23
- Target Price
- WDAY $298.93
- BSX $110.57
- AVG Volume (30 Days)
- WDAY 2.7M
- BSX 10.4M
- Earning Date
- WDAY 05-22-2025
- BSX 04-23-2025
- Dividend Yield
- WDAY N/A
- BSX N/A
- EPS Growth
- WDAY N/A
- BSX 15.23
- EPS
- WDAY 1.95
- BSX 1.37
- Revenue
- WDAY $8,446,000,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- WDAY $14.89
- BSX $15.77
- Revenue Next Year
- WDAY $13.52
- BSX $10.33
- P/E Ratio
- WDAY $122.59
- BSX $74.36
- Revenue Growth
- WDAY 16.35
- BSX 19.36
- 52 Week Low
- WDAY $199.81
- BSX $70.97
- 52 Week High
- WDAY $294.00
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- WDAY 54.53
- BSX 59.77
- Support Level
- WDAY $210.75
- BSX $92.70
- Resistance Level
- WDAY $235.96
- BSX $102.37
- Average True Range (ATR)
- WDAY 10.28
- BSX 3.73
- MACD
- WDAY 2.21
- BSX 0.98
- Stochastic Oscillator
- WDAY 99.19
- BSX 97.19
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.